Ruggie Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ruggie Capital Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,745	Closed	-$197K	–	482
2018 Q4	$197K	Buy	+2,745	New	+$221K	0.09%	111

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ruggie Capital Group's XBI Position: Q1 2019 in Review

Ruggie Capital Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2019, closing a stake of 2,745 shares — an estimated $197K sold.

Ruggie Capital Group first reported a position in XBI in Q4 2018 and held it in 1 quarter. The position peaked at $197K in Q4 2018. 451 funds tracked by Wall St. Rank hold XBI as of Q1 2019.

Ruggie Capital Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2019 after selling out during the quarter.
Ruggie Capital Group sold 2,745 State Street SPDR S&P Biotech ETF shares in Q1 2019, an estimated $197K.
Ruggie Capital Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 1 quarter.
Ruggie Capital Group's State Street SPDR S&P Biotech ETF position peaked at $197K in Q4 2018.
451 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2019.

Based on Ruggie Capital Group's 13F filing for Q1 2019, filed 24 Apr 2019.